cryobiopsy in diffuse parenchymal lung diseases: a large cohort of 699 patients. BMC Pulm Med. 2019 Jan 16;19(1):16. \[[PMC free article: PMC6335717](/pmc/articles/PMC6335717/)\] \[[PubMed: 30651103](https://pubmed.ncbi.nlm.nih.gov/30651103)\] 42. Furini F, Carnevale A, Casoni GL, Guerrini G, Cavagna L, Govoni M, Scir√© CA. The Role of the Multidisciplinary Evaluation of Interstitial Lung Diseases: Systematic Literature Review of the Current Evidence and Future Perspectives. Front Med (Lausanne). 2019;6:246. \[[PMC free article: PMC6842981](/pmc/articles/PMC6842981/)\] \[[PubMed: 31750308](https://pubmed.ncbi.nlm.nih.gov/31750308)\] 43. Cerri S, Monari M, Guerrieri A, Donatelli P, Bassi I, Garuti M, Luppi F, Betti S, Bandelli G, Carpano M, Bacchi Reggiani ML, Tonelli R, Clini E, Nava S. Real-life comparison of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis: A 24-month assessment. Respir Med. 2019 Nov;159:105803. \[[PubMed: 31670147](https://pubmed.ncbi.nlm.nih.gov/31670147)\] 44. Homma S, Bando M, Azuma A, Sakamoto S, Sugino K, Ishii Y, Izumi S, Inase N, Inoue Y, Ebina M, Ogura T, Kishi K, Kishaba T, Kido T, Gemma A, Goto Y, Sasaki S, Johkoh T, Suda T, Takahashi K, Takahashi H, Taguchi Y, Date H, Taniguchi H, Nakayama T, Nishioka Y, Hasegawa Y, Hattori N, Fukuoka J, Miyamoto A, Mukae H, Yokoyama A, Yoshino I, Watanabe K., Ministry of Health, Labour and Welfare, the Study Group on Diffuse Pulmonary Disorders, Scientific Research/Research on Intractable Diseases, and Japanese Respiratory Society. Japanese guideline for the treatment of idiopathic pulmonary fibrosis. Respir Investig. 2018 Jul;56(4):268-291. \[[PubMed: 29980444](https://pubmed.ncbi.nlm.nih.gov/29980444)\] 45. Cheng L, Tan B, Yin Y, Wang S, Jia L, Warner G, Jia G, Jiang W. Short- and long-term effects of pulmonary rehabilitation for idiopathic pulmonary fibrosis: a systematic review and meta-analysis. Clin Rehabil. 2018 Oct;32(10):1299-1307. \[[PubMed: 29843523](https://pubmed.ncbi.nlm.nih.gov/29843523)\] 46. Tolle LB, Southern BD, Culver DA, Horowitz JC. Idiopathic pulmonary fibrosis: What primary care physicians need to know. Cleve Clin J Med. 2018 May;85(5):377-386. \[[PubMed: 29733782](https://pubmed.ncbi.nlm.nih.gov/29733782)\] 47. Harari S, Wells AU, Wuyts WA, Nathan SD, Kirchgaessler KU, Bengus M, Behr J. The 6-min walk test as a primary end-point in interstitial lung disease. Eur Respir Rev. 2022 Sep 30;31(165) \[[PMC free article: PMC9724818](/pmc/articles/PMC9724818/)\] \[[PubMed: 36002171](https://pubmed.ncbi.nlm.nih.gov/36002171)\] 48. Johannson KA, Pendharkar SR, Mathison K, Fell CD, Guenette JA, Kalluri M, Kolb M, Ryerson CJ. Supplemental Oxygen in Interstitial Lung Disease: An Art in Need of Science. Ann Am Thorac Soc. 2017 Sep;14(9):1373-1377. \[[PubMed: 28644693](https://pubmed.ncbi.nlm.nih.gov/28644693)\] 49. Long-Term Oxygen Treatment Trial Research Group. Albert RK, Au DH, Blackford AL, Casaburi R, Cooper JA, Criner GJ, Diaz P, Fuhlbrigge AL, Gay SE, Kanner RE, MacIntyre N, Martinez FJ, Panos